INNOVUS PHARMACEUTICALS, INC. (INNV) has 17 open-market insider trades by 13 insiders since 2013. Over the last six months insiders net sold $185.0M. The most active filer is Richard C. Zoretic, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ignite Aggregator L.P. | 10% Owner | — | 1 | $92.5M | 2026-09-24 |
| TCO GROUP Holdings, L.P. | 10% Owner | — | 1 | $92.5M | 2026-09-24 |
| Thomas Scully | Dir | — | 1 | $1.0M | 2022-09-15 |
| Edward Moore Kennedy Jr. | Dir | — | 1 | $483K | 2026-07-01 |
| Richard C. Zoretic | Dir | — | 3 | $337K | 2026-07-01 |
| Michael Anthony Scarbrough | PresCOO | — | 2 | $285K | 2025-11-14 |
| Bassam Damaj | Pres10% | — | 2 | $254K | 2015-06-26 |
| Maureen Hewitt | CEOPresDir | — | 1 | $249K | 2021-03-12 |
| Barbara Gutierrez | CFO | — | 1 | $53K | 2021-03-12 |
| Robin Doerr | Chief Sales and MKTG Officer | — | 1 | $48K | 2021-03-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nicole Damato | CLO | Sell | $207K | 2026-09-25 |
| TCO GROUP Holdings, L.P. | 10% Owner | Sell | $92.5M | 2026-09-24 |
| Michael Anthony Scarbrough | President & COO | Sell | $162K | 2025-11-14 |
| Richard C. Zoretic | Director | Buy | $312K | 2025-05-28 |
| Richard C. Zoretic | Director | Buy | $12K | 2025-05-21 |
| Richard C. Zoretic | Director | Buy | $12K |
Companies that share insiders with INNV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-05-16 |
| Michael Anthony Scarbrough | President | Buy | $123K | 2025-05-09 |
| Nicole Damato | CLO | Sell | $11K | 2024-11-06 |
| Nicole Damato | CLO | Sell | $71K | 2024-09-16 |
| Nicole Damato | CLO | Sell | $42K | 2023-07-17 |
| Nicole Damato | CLO | Sell | $24K | 2023-07-13 |
| Nicole Damato | CLO | Sell | $9K | 2023-07-11 |
| Nicole Damato | CLO | Sell | $47K | 2023-07-06 |
| Nicole Damato | CLO | Sell | $46K | 2023-07-03 |
| Thomas Scully | Director | Buy | $1.0M | 2022-09-15 |